Evidence map›Paper›PMID 38496354›Full record

ArticleAmerican journal of clinical and experimental immunology2024

Identification of glycosyltransferase-related genes signature and integrative analyses in patients with ovarian cancer.

Yanqiu Zhang, Tong Zhou, Qingqin Tang, Bin Feng, Yuting Liang

Open access · bronzeAbstract read
In one paragraph

Article in American journal of clinical and experimental immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Identification of immune infiltration-related ZNF480 for predicting prognosis in breast cancer.American journal of clinical and experimental immunology · 2025
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Yanqiu ZhangCenter for Clinical Laboratory, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, The People's Republic of China.
Tong ZhouCenter for Clinical Laboratory, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, The People's Republic of China.
Qingqin TangCenter for Clinical Laboratory, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, The People's Republic of China.
Bin FengCenter for Clinical Laboratory, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, The People's Republic of China.
Yuting LiangCenter for Clinical Laboratory, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, The People's Republic of China.
Soochow University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlycosyltransferases (GT) play a crucial role in glycosylation reactions, and aberrant expression of glycosyltransferase-related genes (GTs) leads to abnormal glycosylation, which is associated with tumor progression. However, the prognostic value of aberrant expression of GTs in ovarian cancer (OC) and the correlation between GTs and tumor microenvironment (TME) remain unknown.

methodsTCGA and GSE53963 databases were used to obtain data on OC patient samples. The association of GTs with OC was analyzed. Molecular subtypes were identified by consensus unsupervised clustering, followed by immune infiltration and functional enrichment analyses. Survival analysis was performed using Kaplan-Meier curves and log-rank tests. Least Absolute Shrinkage and Selection Operator (LASSO) and multifactorial cox regression were used to screen for signature genes associated with OC and used to establish prognostic models.

resultOC patients were categorized into 5 GTs clusters using consensus unsupervised cluster analysis. Clusters D and E showed significant differences between survival, signaling pathways and immune infiltration. Then, a risk model was developed based on the 12 signature genes, which provides a more accurate evaluation of the prognosis of OC patients. We categorized patients into high-risk and low-risk groups based on the risk score and found that the survival of patients in the high-risk group was significantly lower than that in the low-risk group. Moreover, the risk score was significantly correlated with tumor microenvironment, immune infiltration, and chemotherapy sensitivity.

conclusionOverall, we performed a comprehensive analysis of GTs in OC patients and developed a risk model for OC. Our findings will provide a new insight to OC prognosis and treatment.

Indexed as

Glycosyltransferaseimmune cell infiltrationovarian cancertumor microenvironment

Identifiers

PMID38496354
PMCPMC10944358
OpenAlexW4394764907

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.